NervGen Pharma Corp. (NGEN) Tops Q1 EPS by 6c

NervGen Pharma Corp. (NASDAQ: NGEN) reported Q1 EPS of ($0.02), $0.06 better than the analyst estimate of ($0.08).

For earnings history and earnings-related data on NervGen Pharma Corp. (NGEN) click here.

You May Also Be Interested In

• Wells Fargo Upgrades Portland General Electric Company (POR) to Overweight
• Wells Fargo Starts Vivmark Residential (VMRK) at Overweight, 'Setting the mark for growth'
• ZKH Group Limited (ZKH) Reports Q2 EPS of $0.04